Related Experiment Video
Updated: Jan 24, 2026

Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
Propofol-based palliative sedation in terminally ill children with solid tumors: A case series
Evelina Miele1, Mastronuzzi Angela1, M Giuseppina Cefalo1
1Department of Hematology/Oncology and Stem Cell Transplantation, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS).
Insights
Propofol effectively manages refractory symptoms in pediatric oncology patients undergoing palliative sedation. This study shows propofol, an anesthetic, is a tolerable option for end-of-life care in children with solid tumors.
Area of Science:
- Oncology
- Palliative Care
- Pharmacology
Background:
- Palliative sedation therapy involves reducing the alert state using pharmacological agents.
- Propofol, a short-acting anesthetic, is rarely used in palliative care.
- Managing refractory symptoms in terminally ill pediatric oncology patients is challenging.
Purpose of the Study:
- To evaluate the quality and effectiveness of propofol-based palliative sedation.
- To assess propofol as an adjuvant therapy for intractable suffering in pediatric oncology.
- To determine the feasibility of propofol for end-of-life palliative sedation in children.
Main Methods:
- A case series of 5 pediatric oncology inpatients with relapsed/refractory solid tumors.
- Palliative sedation administered using propofol alone or in combination with opioids and benzodiazepines.
- Evaluation of symptom control and patient outcomes.
Main Results:
- Propofol-based palliative sedation effectively controlled refractory symptoms and psychological suffering.
- Some patients reduced opioid consumption after initiating propofol.
- Progressive sedation with propofol was the only effective measure for symptom control until death.
Conclusions:
- Propofol is an effective and tolerable adjuvant drug for managing intractable suffering in pediatric oncology.
- Propofol offers a practicable strategy for palliative sedation in end-of-life pediatric oncology care.
- This approach aids in controlling refractory symptoms and psychological distress in terminally ill children.
Rationale:
The palliative sedation therapy is defined as the intentional reduction of the alert state, using pharmacological tools. Propofol is a short-acting general anesthetic agent, widely used for induction and maintenance of general anesthesia and rarely employed in palliative care.
Patient Concerns And Diagnoses:
This case series describes 5 pediatric oncology inpatients affected by relapsed/refractory solid tumors received palliative sedation using propofol alone or in combination with opioids and benzodiazepines.
Interventions And Outcomes:
Five terminally ill children affected by solid tumors received propofol-based palliative sedation. All patients were previously treated with opioids and some of them reduced the consumption of these drugs after propofol starting. In all cases the progressive increase of the level of sedation until the death has been the only effective measure of control of refractory symptoms related todisease progression and psychological suffering.
Lessons:
We evaluated the quality of propofol-based palliative sedation in a series of pediatric oncology patients with solid tumors at the end of their life. We concluded that propofol represents an effective and tolerable adjuvant drug for the management of intractable suffering and a practicable strategy for palliative sedation in pediatric oncology patients at the end of their life.
Related Concept Videos
Termination of Translation
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Metallic Solids
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
Structures of Solids

